Routine sentinel node detection in breast cancer. Experience of the Curie Institute;Le ganglion sentinelle en routine dans le cancer du sein: Expérience de l'Institut Curie

Bulletin du Cancer

Volumn 91, Issue 7-8, 2004, Pages 641-647

  Delahaye, Sophie ^a   Benamor, Myriam ^b   Nos, Claude ^a   Vincent Salomon, Anne ^c   El Khoury, Carl ^b   Doridot, Virginie ^a   Sigal Zafrani, Brigitte ^c   Clough, Krishna B ^a  

^a Serv Chir Gen Orient Senologique   (France)

^b Dept d'Imagerie Medicale ^*  (France)

^c INSTITUT CURIE   (France)

Author keywords

Breast cancer; Micrometastasis; Sentinel lymph node; Surgical treatment

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CENTER; CANCER SURGERY; DIAGNOSTIC TEST; EXPERIENCE; FOLLOW UP; HUMAN; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; MEDICAL SPECIALIST; SENTINEL LYMPH NODE BIOPSY; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; REOPERATION; SENTINEL LYMPH NODE BIOPSY;

EID: 4344692006     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993 ; 2 : 335-40.
2. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994 ; 220 : 391-401.
3. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997 ; 349 : 1864-7.
4. Schwartz GF, Giuliano AE, Veronesi U, and the consensus conference committee. Proceedings of the consensus conference of sentinel node biopsy in carcinoma of the breast April 19-22, 2001, Philadelphia, PA, USA. Cancer 2002 ; 94 : 2542-51.
5. Bobin JY, Carrier P, Constantinesco A, Darcourt J, Ettore F, Gérard JP, et al. Recommandations pour le marquage lymphatique et la biopsie du ganglion sentinelle dans le cancer du sein T0 T1 T2 N0 M0. In : Nouvelles techniques, nouvelles thérapeutiques : nouvelles stratégies. Sous la direction de M Namer et JM Ferrero. Ed. Springer, 2003.
6. Salmon RJ, Marcollet A, Doridot V, Clough KB. Identification du ganglion sentinelle dans le cancer du sein : aspects logistiques. Bull Cancer 2003 ; 90 : 1049-54.
7. Salmon RJ, Fried D. Mise en évidence du ganglion sentinelle dans le curage axillaire pour cancer du sein. Presse Med 1998 ; 27 : 509-12.
8. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C et al. The sentinel node in breast cancer : a multicenter validation study. N Engl J Med 1998 ; 339 : 941-6.
9. McMasters KM, Wong SL, Chao C, Woo C, Tuttle TM, Noyes RD, Carlson DJ et al. Defining the optimal surgeon experience for breast cancer sentinel node biopsy : a model for implementation of new surgical techniques. Ann Surg 2001 ; 234 : 292-9.
10. Nieweg OE, Estourgie SH, Valdes Olmos RA, Rutgers EJT, Hoefnagel CA, Kroon BBR. Lymphatic mapping with tracer administration into the primary breast cancer. Eur J Surg Oncol 2003 ; 39 : 95-7.
11. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph bnode biopsy versus axilla lymph node dissection for patients with breast carcinoma. Cancer 2000 ; 88 : 608-14.
12. Veronesi U, Paganelli G, Viale G, Luini S, Galimberti V et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003 ; 349 : 603-5.
13. Cox CE, Nguyen K, Gray RJ, Salud C, Ku NN, Dupont E, Hutson L et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS) : why map DCIS ? Am Surg 2002 ; 68 : 500-2.
14. Bobin JY, Spirito C, Isaac S, Zinzindohoue C, Joualee A, Khaled M, et al. Le marquage lymphatique et la biopsie du ganglion sentinelle axillaire dans 243 cancers invasifs du sein sans ganglion palpable. Expérience du centre hospitalier Lyon-Sud. Ann Chir 2000 ; 125 : 861-70.
15. Mariani G, Moresco L, Viale G, Villa G, Bagnasco M, Canavese G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001 ; 42 : 1198-215.
16. Benamor M, Nos C, Fréneaux P, Clough K. Impact of internal mammary sentinel node imaging in breast cancer. Clin Nuc Med 2003 ; 28 : 375-8.
17. Cody HS, Fey J, Akhurst T, Fazzari M, Mazumdar M et al. Complementarity of blue dye and isotope in sentinel localization for breast cancer : univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 2001 ; 8 : 13-9.
18. Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer : impact of the number of sentinel nodes removed on the false negative rate. J Am Coll Surg 2001 ; 192 : 684-91.
19. Sauer T, Engh V, Holk AM, et al. Imprint cytology of sentinel lymph nodes in breast cancer. Experience with rapid, intraoperative diagnosis and primary screening by cytotechnologists. Acta Cytol 2003 ; 768-73.
20. International union against cancer (Union internationale contre le cancer) 2003 http://tnm.uicc.org.
21. Nos C, Harding-MacKean C, Fréneaux P, Trie A, Falcou MC, Sastre-Garau X, et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surgery 2003 ; 90 : 1354-60.
22. Viale G, Maiorano E, Mazzarol G, Zurrida S, Galimberti V, Luini A, et al. Histologic detection and clinical implications of micrometastes in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001 ; 92 : 1378-84.
23. Marin C, Mathelon, Neuville A, Mertz L, Constantinesco A. Ganglions sentinelles avec micrométastases dans le cancer du sein : données histologiques et implications chirurgicales. À propos d'une série de 201 curages axillaires après identification peropératoire des ganglions sentinelles. Bull Cancer 2003 ; 90 : 459-65.
24. Hurkmans CW, Borger JH, Rutgers EJ, van Tienhoven G. Quality assurance of axillary radiotherapy in rhe EORTC Amaros trial 10981/22023 : the dummy run. Radiother Oncol 2003 ; 68 : 233-40.
25. Breast study announcements. Durham, NC : American college of surgeons oncology group, 2003 (www.acosog.org/studies/organ-site/breast/).
26. Warnberg F, Bundred N. Will early derection of non-axillary sentinel nodes afffect treatment decisions ? Br J Cancer 2002 ; 87 : 691-3.
27. Krag DN, Julian T. Expert perspectives : update on NSABP-32, a randomized phase III clinical trial ro compare sentinel node resection to conventional axillary dissection for clinically node-negative breast cancer. Breast Dis Year Book Q 2002 ; 13 : 113-4.
28. Nos C, Fréneaux P, Guilbert S, Falcou MC, Salmon RJ, Clough KB. Sentinel lymph node detection for breast cancer : which patients are best suited for rhe patent blue dye only method of identification ? Ann Surg Oncol 2001 ; 8 : 438-43.
29. Nos C, Fréneaux P, Louis-Sylvestre C, Hurren JS, Heitz D, Sastre-Garau X, et al. Macroscopic quality control improves the reliability of blue dye only sentinel lymph node biopsy in breast cancer. Ann Surg Oncol 2003 ; 10 : 525-30.
30. Maublanr J, Cachin F, Mesras D, Geissler B. Le repérage du ganglion sentinelle en médecine nucléaire. Bull Cancer 2002 ; 89 : 671-80.
31. Fréneaux P, Nos C, Vincent-Salomon A, Genin P, Sigal-Safrani B, Al Ghuzlan A, et al. Histological derection of minimal metastatic involvement in axillary sentinel nodes : a rational basis for a sensitive methodology usable in daily practice. Mod Pathol 2002 ; 15 : 641-6.